MarketsTakeda Pharmaceutical

Takeda Pharmaceutical

TSE:4502equity
5,570+90.00 (+1.64%)Tokyo · JPY
TSE:4502
Data: Yahoo Finance · Prices may be delayed 15–20 minYahoo Finance Japan →

Previous close

5,480

Open

5,480

Day's range

5,471 – 5,621

52-week range

4,102 – 6,033

Volume

3,388,000

Currency

JPY

About Takeda Pharmaceutical Company Limited

武田薬品工業株式会社

Takeda Pharmaceutical Company Limited is a global biopharmaceutical company headquartered in Japan. It develops, manufactures, and markets prescription medicines primarily focused on oncology, gastroenterology, neuroscience, and rare diseases. The company operates worldwide, with significant commercial presence in Japan, the United States, and Europe.

Why investors watch it

Takeda is one of Japan's largest pharmaceutical firms and a key player in the global healthcare sector. Foreign investors monitor its stock for exposure to Japan's healthcare market and its strategic growth through acquisitions and R&D. The company's performance can also be influenced by currency fluctuations and Japanese economic policies, including those of the Bank of Japan.

HQ: Chuo, Osaka, JapanFounded: 1781Reviewed: Jul 2026

No news found for Takeda Pharmaceutical.

Press Releases

All releases →

No press releases found for Takeda Pharmaceutical.

Symbol: TSE:4502Yahoo Finance: 4502.TType: equityAlso known as: takeda · 武田薬品

Market data is indicative and delayed 15–20 min. Not investment advice.

KaneWire NetworkKaneWireBusiness NewswireKaneForexForex & CurrencyKaneCryptoCrypto & BlockchainKaneStocksJapan Equitiesyou are hereKaneAIJapanAI in Japan & Asia